Literature DB >> 10759697

Reply

.   

Abstract

Year:  2000        PMID： 10759697      PMCID： PMC2014939          DOI： 10.1046/j.1365-2125.2000.0183r.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Binding of propofol to blood components.

Authors:  E Suarez; R Calvo; M K Zamacona; J Lukas
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

2.  Serum protein binding of propofol in critically ill patients.

Authors:  M K Zamacona; E Suárez; L Aguilera; C Aguirre; R Calvo
Journal:  Acta Anaesthesiol Scand       Date:  1997-11       Impact factor: 2.105

3.  Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis.

Authors:  J L Costela; R Jiménez; R Calvo; E Suárez; R Carlos
Journal:  Acta Anaesthesiol Scand       Date:  1996-07       Impact factor: 2.105

4.  The significance of lipoproteins in serum binding variations of propofol.

Authors:  M K Zamacona; E Suárez; E García; C Aguirre; R Calvo
Journal:  Anesth Analg       Date:  1998-11       Impact factor: 5.108

5.  Propofol binding to human blood proteins.

Authors:  P Altmayer; U Büch; H P Büch
Journal:  Arzneimittelforschung       Date:  1995-10
  5 in total
  1 in total

1.  [Influence of propofol dose and blood components on duration of electrical seizures in electroconvulsive therapy].

Authors:  María Luisa González Moral; Carmen Selva Sevilla; Patricia Romero Rodenas; María Teresa Tolosa Pérez; Marta Lucas Pérez-Romero; Mar Domato Lluch; Manuel Gerónimo Pardo
Journal:  Braz J Anesthesiol       Date:  2018-08-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.